Clin2
NCT07693244Possibly a fitRecruiting

Exosome therapy for male pattern baldness

Androgenetic Alopecia (AGA)

Part of Skin clinical trials.

This trial tests a new treatment using exosomes (tiny particles that help cells communicate) for male pattern baldness. It may help regrow hair or slow further loss.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
120 people
Ages
18 years to 55 years
Study type
Interventional

Who can take part

  • Men ages 18 to 55 with male pattern baldness (Norwood-Hamilton grade III-V).
  • Hair loss has been stable (not getting worse) for at least 6 months.
  • You agree not to use any other hair loss treatments during the study and for 6 months after.
  • You have not used hair loss medications like minoxidil or finasteride in the past year.
  • You have not had scalp procedures (like PRP or laser cap) in the past 6 months.
  • You do not have other types of hair loss, active scalp infections, autoimmune disease, or certain health conditions.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06764329Enrolling by invitation· Phase 1/Phase 2
Stem cell therapy for male hair loss

This trial tests if injecting donor stem cells into the scalp can help regrow hair in men with male pattern baldness. It may offer a new option for those who haven't found other treatments effective.

Rawalpindi
NCT07327359Recruiting· Phase 1/Phase 2
Study of OLX72021 for male pattern baldness

This trial tests an investigational drug called OLX72021 for male pattern hair loss (androgenetic alopecia). It aims to see if the drug is safe and effective in healthy men with mild to moderate hair loss.

Camberwell, Victoria
NCT07603544Recruiting
Hair Loss Study: Understanding Male Pattern Baldness

This research study examines what causes male pattern baldness (androgenetic alopecia) by studying hair, skin, and biological samples from men with hair loss and healthy men. The goal is to better understand why hair loss happens so scientists can develop better treatments.

Xinxiang, Henan
NCT07529977Not yet recruiting· Phase 3
Oral Minoxidil for Male Hair Loss Treatment

This trial tests a new oral (pill) form of minoxidil to help regrow hair in men with male-pattern baldness. Minoxidil is a known hair-growth medication, and this study evaluates whether taking it as a pill works safely and effectively.

NCT07758400Not yet recruiting
Microneedling for male pattern baldness

This study tests whether microneedling, a procedure that uses tiny needles to stimulate the scalp, can help treat male pattern baldness. It may help regrow hair in men with moderate to advanced hair loss.

Beijing, Beijing Municipality
NCT07203599Recruiting· Phase 1/Phase 2
Stem cell exosomes for male pattern baldness

This trial tests a treatment made from umbilical cord stem cell exosomes for young men with male pattern baldness. It aims to see if this natural substance can help regrow hair.

Shenzhen, Guangdong

Hear when a new Androgenetic Alopecia (AGA) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.